Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

Lamar Advertising (NASDAQ:LAMR – Get Free Report) has earned an average recommendation of “Hold” from the five brokerages that are covering the stock, Marketbeat reports. Four investment analysts have ...

In a report released today, Andrew Kligerman from TD Cowen maintained a Buy rating on Kemper (KMPR – Research Report), with a price target of ...

TD Cowen analyst Michael Nedelcovych maintained a Buy rating on Novo Nordisk (NVO – Research Report) today. The company’s shares closed ...

After several pushbacks, we're now on the precipice of having the 2025 class of Oscars nominees revealed.

Wieden+Kennedy London has taken this non-traditional approach, commissioning nine London-based artists and makers to create ...

"Top 10s delivers expertly crafted videos featuring in-depth analysis, exclusive visuals, and engaging infographics on a variety of topics. From intriguing mysteries to groundbreaking discoveries, Top ...

Organic growth for the spices and sauces maker is still expected to improve on 2024’s 1% pace at the top-end of the forecast ...

TD Cowen analysts highlighted Oracle as a key beneficiary. OpenAI plans to shift some AI training workloads from Microsoft Azure to Oracle Cloud Infrastructure (OCI) under restructured terms ...

The rise in targets in recent days, however, pushes the stock toward $360 after UBS Group raised its target on Salesforce and maintained a "neutral" rating, and Needham & Company raised the price ...

One local business in Kansas City has expanded from just making merchandise using red and gold. Just last month, Cherry Co., a women-owned clothing brand, became an official partner with the Kansas ...